Qube Research & Technologies LTD Anixa Biosciences Inc Transaction History

Qube Research & Technologies LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.21 - $3.35 $206,281 - $312,689	-93,340 Reduced 100.0%	3 $0
Q1 2024 May 14, 2024	BUY	$3.08 - $5.02 $138,261 - $225,347	44,890 Added 92.65%	93,343 $291,000
Q4 2023 Feb 13, 2024	BUY	$2.85 - $4.19 $138,079 - $203,001	48,449 Added 1211225.0%	48,453 $187,000
Q3 2023 Nov 13, 2023	BUY	$2.97 - $3.87 $11 - $15	4 New	4 $0
Q4 2022 Feb 14, 2023	BUY	$3.78 - $5.81 $85,851 - $131,956	22,712 New	22,712 $96,000
Q2 2021 Aug 13, 2021	SELL	$3.46 - $4.92 $45,993 - $65,401	-13,293 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$3.27 - $7.14 $212,514 - $464,021	-64,989 Reduced 83.02%	13,293 $62,000
Q4 2020 Feb 16, 2021	SELL	$1.94 - $3.19 $113,635 - $186,854	-58,575 Reduced 42.8%	78,282 $240,000
Q3 2020 Nov 12, 2020	BUY	$1.79 - $3.3 $197,345 - $363,821	110,249 Added 414.35%	136,857 $333,000
Q2 2020 Aug 14, 2020	BUY	$1.53 - $3.06 $40,710 - $81,420	26,608 New	26,608 $81,000

5.48M

21K

6.7K

Ticker ANIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,661,700
Market Cap $96M
Description
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.